Carmell Therapeutics (NASDAQ:CTCX) just reported results for the first quarter of 2024.
- Carmell Therapeutics reported earnings per share of -16 cents.
- The company did not report any revenue for the quarter.
Please enter the email address associated with your account and we'll send you a magic link for a password-free sign in.
The provided email address must be associated with an account to receive a login link. If you can't find the email, please check your spam folder.
Enter your existing account details once to link them to this sign-in method.
Not Yet a Premium Subscriber?
Subscribe